![Lothar H. Finke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lothar H. Finke
Corporate Officer/Principal at
INCYTE CORPORATION
Profile
Lothar H.
Finke's career history includes current and former positions as well as his education.
Currently, he is the Group Vice President & General Manager at Incyte Corp.
Previously, he worked as a Principal at Merck KGaA from 1995 to 2004 and as the Chief Medical Officer at Argos Therapeutics, Inc. from 2004 to 2009.
He also held positions as a Principal at Lexigen Pharmaceuticals Corp.
and EMD Pharmaceuticals, Inc. Additionally, he worked as a Principal at the Basel Institute for Immunology from 1993 to 1994.
Dr. Finke obtained a doctorate degree from Philipps University of Marburg.
Lothar H. Finke active positions
| Companies | Position | Start |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 2017-05-31 |
Former positions of Lothar H. Finke
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2009-01-31 |
| MERCK KGAA | Corporate Officer/Principal | 2004-06-30 |
Basel Institute for Immunology
 Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1993-12-31 |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Developer of cancer therapy treatments | Corporate Officer/Principal | - |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Corporate Officer/Principal | - |
Training of Lothar H. Finke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Developer of cancer therapy treatments | Commercial Services |
Philipps University of Marburg
 Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Basel Institute for Immunology
Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Lothar H. Finke
